Calcification Microstructure Reflects Breast Tissue Microenvironment
dc.contributor.author | Gosling, S | |
dc.contributor.author | Scott, R | |
dc.contributor.author | Greenwood, C | |
dc.contributor.author | Bouzy, P | |
dc.contributor.author | Nallala, J | |
dc.contributor.author | Lyburn, I | |
dc.contributor.author | Stone, N | |
dc.contributor.author | Rogers, K | |
dc.date.accessioned | 2019-12-04T09:39:11Z | |
dc.date.issued | 2019-12-05 | |
dc.description.abstract | Microcalcifications are important diagnostic indicators of disease in breast tissue. Tissue microenvironments differ in many aspects between normal and cancerous cells, notably extracellular pH and glycolytic respiration. Hydroxyapatite microcalcification microstructure is also found to differ between tissue pathologies, including differential ion substitutions and the presence of additional crystallographic phases. Distinguishing between tissue pathologies at an early stage is essential to improve patient experience and diagnostic accuracy, leading to better disease outcome. This study explores the hypothesis that microenvironment features may become immortalised within calcification crystallite characteristics thus becoming indicators of tissue pathology. In total, 55 breast calcifications incorporating 3 tissue pathologies (benign – B2, ductal carcinoma in-situ - B5a and invasive malignancy - B5b) from archive formalin-fixed paraffin-embedded core needle breast biopsies were analysed using X-ray diffraction. Crystallite size and strain were determined from 548 diffractograms using WilliamsonHall analysis. There was an increased crystallinity of hydroxyapatite with tissue malignancy compared to benign tissue. Coherence length was significantly correlated with pathology grade in all basis crystallographic directions (P<0.01), with a greater difference between benign and in situ disease compared to in-situ disease and invasive malignancy. Crystallite size and non-uniform strain contributed to peak broadening in all three pathologies. Furthermore, crystallite size and non-uniform strain normal to the basal planes increased significantly with malignancy (P<0.05). Our findings support the view that tissue microenvironments can influence differing formation mechanisms of hydroxyapatite through acidic precursors, leading to differential substitution of carbonate into the hydroxide and phosphate sites, causing significant changes in crystallite size and non-uniform strain. | en_GB |
dc.description.sponsorship | Cancer Research UK | en_GB |
dc.description.sponsorship | KWF Kankerbestrijding | en_GB |
dc.identifier.citation | Published online 5 December 2019 | en_GB |
dc.identifier.doi | 10.1007/s10911-019-09441-3 | |
dc.identifier.grantnumber | C38317/A24043 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/39933 | |
dc.language.iso | en | en_GB |
dc.publisher | Springer | en_GB |
dc.rights | © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Hydroxyapatite | en_GB |
dc.subject | Carbonate | en_GB |
dc.subject | Breast Cancer | en_GB |
dc.subject | Calcification | en_GB |
dc.subject | X-ray diffraction | en_GB |
dc.title | Calcification Microstructure Reflects Breast Tissue Microenvironment | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2019-12-04T09:39:11Z | |
dc.identifier.issn | 1083-3021 | |
dc.description | This is the final version. Available on open access from Springer via the DOI in this record | en_GB |
dc.identifier.journal | Journal of Mammary Gland Biology and Neoplasia | en_GB |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_GB |
dcterms.dateAccepted | 2019-11-27 | |
exeter.funder | ::Cancer Research UK | en_GB |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2019-11-28 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2019-12-03T18:44:59Z | |
refterms.versionFCD | AM | |
refterms.dateFOA | 2025-03-06T20:35:01Z | |
refterms.panel | B | en_GB |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © The Author(s) 2019
Open Access
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/